-

U.S. Department of Health and Human Services Awards CITI and C3 AI $90 Million Agreement

The joint Blanket Purchase Agreement will enable HHS to rapidly deploy and scale enterprise AI solutions across the department, including the NIH, FDA, and CDC

REDWOOD CITY, Calif.--(BUSINESS WIRE)--The U.S. Department of Health and Human Services (HHS) has awarded a joint $90 million, five-year agreement to CITI, the software services and product company, and C3 AI (NYSE: AI), the Enterprise AI application software company, through its partnership with Carahsoft.

The Blanket Purchase Agreement (BPA), called “Solutioning with Holistic Analytics Restructured for the Enterprise (SHARE),” will accelerate enterprise AI deployments across the entire HHS, which includes the National Institutes of Health (NIH), the Food and Drug Administration (FDA), and the Centers for Disease Control and Prevention (CDC).

Through the SHARE BPA, the HHS’s various agencies and missions can select C3 AI to support data-driven work. For example, the HHS can leverage the C3 AI Application Platform to rapidly deploy use cases and scale AI applications to solve public health challenges in the event of a future pandemic. The BPA allows HHS officials to procure CITI services, C3 AI applications, and C3 AI’s secure and powerful AI platform for data collection, analysis with machine learning, and predictive AI capabilities.

“Our public health agencies, including the FDA and CDC, are under incredible pressure to solve complex, life-threatening problems, ranging from supply chain optimization for baby formula to understanding and thwarting the next global pandemic. These problems cannot be solved without machine learning and enterprise AI capabilities,” said Thomas M. Siebel, Chairman and CEO of C3 AI. “We are proud to deliver the world’s leading AI technologies, people, and partners to HHS, and we look forward to supporting the department’s vital missions.”

“I am very pleased to partner with C3 AI and provide agile development services to HHS agencies to integrate the C3 AI platform via this new SHARE BPA,” said Sunil Kolhekar, President and CEO of CITI.

Over the past two years, C3 AI’s software has been used extensively by data and research communities to combat the COVID-19 pandemic, while CITI has been at the forefront of developing applications to process expedited payments for farmers hurt by COVID. In April 2020, C3 AI deployed the C3 AI COVID-19 Data Lake to provide the global research community access to critical data to aid mitigation efforts. C3 AI also supported COVID-19-related research through various grant and funding programs, awarding more than $5 million in funding to research teams in 2020 through the C3.ai Digital Transformation Institute and C3 AI COVID-19 Grand Challenge.

C3 AI products are provided via General Services Administration (GSA) Schedules contract with Carahsoft. The BPA No. is 75P001-22-A-00009.

For more information on C3 AI and Enterprise AI solutions, visit https://c3.ai/what-is-enterprise-ai/.

About C3.ai, Inc.

C3 AI is the Enterprise AI application software company. C3 AI delivers a family of fully integrated products including the C3 AI Application Platform, an end-to-end platform for developing, deploying, and operating enterprise AI applications and C3 AI Applications, a portfolio of industry-specific SaaS enterprise AI applications that enable the digital transformation of organizations globally.

About CITI - US

The company was founded in 1996 and is based in Falls Church, Virginia, with offices across the United States, Europe, South Asia, and Canada. CITI is a varied organization with a broad group of IT and business experts providing services to the Federal Government, State &Local and commercial. CITI is a product innovator and has built several enterprise class products in Health and Human Services market using agile and DevSecOps methodologies. CITI’s products modernize use cases for Child Subsidy, Child Welfare and Child Support, Healthcare and Identity Management. CITI holds certifications for ISO 9001:2015, ISO 20000-1:2011, ISO 27001:2013, and CMMI-DEV Maturity Level 4. CITI specializes in the innovative application of agile processes and new technologies as a Microsoft Gold Partner.

For more information on services and products offered by CITI, visit http://citi-us.com.

Contacts

C3 AI Public Relations

Edelman
Lisa Kennedy
415-914-8336
pr@c3.ai

Investor Relations
IR@C3.ai

C3.ai

NYSE:AI

Release Versions

Contacts

C3 AI Public Relations

Edelman
Lisa Kennedy
415-914-8336
pr@c3.ai

Investor Relations
IR@C3.ai

More News From C3.ai

C3 AI Board Member Jim Hagemann Snabe Appointed European Commission Special Envoy for Industrial AI

REDWOOD CITY, Calif.--(BUSINESS WIRE)--C3 AI (NYSE: AI), the enterprise AI application software company, today announced that Jim Hagemann Snabe, a member of its Board of Directors and special advisor to Chairman and Chief Executive Officer Thomas M. Siebel, has been appointed by the European Commission as Special Envoy for Industrial Artificial Intelligence. In this role, he will advise Commission President Ursula von der Leyen and Executive Vice-President Henna Virkkunen. Snabe will take a le...

C3 AI and Shell Expand Collaboration, Scaling Reliability AI Deployment Across Global Asset Operations

REDWOOD CITY, Calif.--(BUSINESS WIRE)--C3 AI (NYSE: AI) today announced that Shell Information Technology International B.V. (“Shell”) is extending its long-standing collaboration with C3 AI across its global operations. C3 AI has worked with Shell since 2018 to deploy and operate an enterprise-scale predictive maintenance program, monitoring more than 13,000 pieces of equipment. Under a new multi-year agreement, Shell will extend its deployment of C3 AI Reliability to enhance its operations, e...

C3 AI Announces Fiscal Fourth Quarter and Full Fiscal Year 2026 Results

REDWOOD CITY, Calif.--(BUSINESS WIRE)--C3.ai, Inc. (“C3 AI,” “C3,” or the “Company”) (NYSE: AI), the Enterprise AI application software company, today announced financial results for its fiscal fourth quarter and full fiscal year ended April 30, 2026. “We have a well-defined strategy, a restructured organization, new executive leadership, and a detailed execution plan now in place with the singular focus of increasing shareholder value through topline revenue growth, cash generation, and non-GA...
Back to Newsroom